Article Details
Retrieved on: 2024-12-08 04:42:21
Tags for this article:
Click the tags to see associated articles and topics
Summary
The article discusses Beam Therapeutics' success in using BEAM-101 for sickle cell disease, highlighting its link to regenerative medicine. The treatment increased fetal hemoglobin levels, reduced sickle hemoglobin, and resolved anemia, demonstrating Beam's innovative approach in hemoglobinopathy treatment.
Article found on: quantisnow.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here